Self-collected cervicovaginal sampling for site-of-care primary HPV-based cervical cancer screening: a pilot study in a rural underserved Greek population

References

• Agorastos T, Chatzistamatiou K, Katsamagkas T, Koliopoulos G, Daponte A, Constantinidis T, et al. 2015. Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology. PLoS One 10:e0119755.
   PubMed Web of Science ®Google Scholar
• Agorastos T, Chatzistamatiou K, Zafrakas M, Siamanta V, Katsamagkas T, Constantinidis TC, et al. 2014. Epidemiology of HPV infection and current status of cervical cancer prevention in Greece: final results of the LYSISTRATA cross-sectional study. European Journal of Cancer Prevention 23:425–431.
   PubMed Web of Science ®Google Scholar
• Agorastos T, Dinas K, Lloveras B, Font R, Kornegay JR, Bontis J, et al. 2005. Self-sampling versus physician-sampling for human papillomavirus testing. International Journal of STD & AIDS 16:727–729.
   PubMed Web of Science ®Google Scholar
• Agorastos T, Lambropoulos AF, Sotiriadis A, Mikos T, Togaridou E, Emmanouilides CJ. 2009. Prevalence and distribution of high-risk human papillomavirus in Greece. European Journal of Cancer Prevention 18:504–509.
   PubMed Web of Science ®Google Scholar
• Anttila A, Von Karsa L, Aasmaa A, Fender M, Patnick J, Rebolj M, et al. 2009. Cervical cancer screening policies and coverage in Europe. European Journal of Cancer 45:2649–2658.
   PubMed Web of Science ®Google Scholar
• Arbyn M, Castle PE. 2015. Offering self-sampling kits for HPV testing to reach women who do not attend in the regular cervical cancer screening program. Cancer Epidemiology, Biomarkers & Prevention 24:769–772.
   PubMed Web of Science ®Google Scholar
• Arbyn M, Verdoodt F, Snijders PJ, Verhoef VM, Suonio E, Dillner L, et al. 2014. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncology 15:172–183.
   PubMed Web of Science ®Google Scholar
• Castle PE, Stoler MH, Wright TC, JR., Sharma A, Wright TL, Behrens CM. 2011. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncology 12:880–890.
   PubMed Web of Science ®Google Scholar
• De Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, et al. 2007. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infectious Diseases 7:453–459.
   PubMed Web of Science ®Google Scholar
• Elfstrom KM, Arnheim-Dahlstrom L, Von Karsa L, Dillner J. 2015. Cervical cancer screening in Europe: quality assurance and organisation of programmes. European Journal of Cancer 51:950–968.
   PubMed Web of Science ®Google Scholar
• Gok M, Van Kemenade FJ, Heideman DA, Berkhof J, Rozendaal L, Spruyt JW, et al. 2012. Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program. International Journal of Cancer 130:1128–1135.
   PubMed Web of Science ®Google Scholar
• Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, et al. 2015. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Obstetrics & Gynecology 125:330–337.
   PubMed Web of Science ®Google Scholar
• Jemal A, Ward E, Thun M. 2010. Declining death rates reflect progress against cancer. PLoS One 5:e9584.
   PubMed Web of Science ®Google Scholar
• Koss LG. 1989. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA 261:737–743.
   PubMed Web of Science ®Google Scholar
• Lazcano-Ponce E, Lorincz AT, Torres L, Salmeron J, Cruz A, Rojas R, et al. 2014. Specimen self-collection and HPV DNA screening in a pilot study of 100,242 women. International Journal of Cancer 135:109–116.
   Google Scholar
• Quinn M, Babb P, Jones J, Allen E. 1999. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ 318:904–908.
   PubMed Web of Science ®Google Scholar
• Ronco G, Dillner J, Elfstrom KM, Tunesi S, Snijders PJ, Arbyn M, et al. 2014. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 383:524–532.
   PubMed Web of Science ®Google Scholar
• Sultana F, English DR, Simpson JA, Drennan KT, Mullins R, Brotherton JM, et al. 2016. Home-based HPV self-sampling improves participation by never-screened and under-screened women: Results from a large randomized trial (iPap) in Australia. International Journal of Cancer 139:281–290.
   PubMed Web of Science ®Google Scholar
• Szarewski A, Cadman L, Mallett S, Austin J, Londesborough P, Waller J, et al. 2007. Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting. Journal of Medical Screening 14:34–42.
   PubMed Web of Science ®Google Scholar
• Tamalet C, Halfon P, Retraite LL, Grob A, Leandri FX, Heid P, et al. 2016. Genotyping and follow-up of HR-HPV types detected by self-sampling in women from low socioeconomic groups not participating in regular cervical cancer screening in France. Journal of Clinical Virology 78:102–107.
   PubMed Web of Science ®Google Scholar
• Verdoodt F, Jentschke M, Hillemanns P, Racey CS, Snijders PJ, Arbyn M. 2015. Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials. European Journal of Cancer 51:2375–2385.
   PubMed Web of Science ®Google Scholar
• Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of Pathology 189:12–19.
   PubMed Web of Science ®Google Scholar